lifestyle.thedishh.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Goodyear Announces Q3 2025 Results, Completes Sale of Chemical Business

    Goodyear Announces Q3 2025 Results, Completes Sale of Chemical Business

    The Goodyear Tire & Rubber Company
    November 4, 2025
  • Howmet Aerospace Inc. Announces Pricing of Debt Offering

    Howmet Aerospace Inc. Announces Pricing of Debt Offering

    Howmet Aerospace, Inc.
    November 4, 2025
  • Realty Income Announces Operating Results for the Three and Nine Months Ended September 30, 2025

    Realty Income Announces Operating Results for the Three and Nine Months Ended September 30, 2025

    REALTY INCOME CORPORATION
    November 4, 2025
  • AI Event Marketing Drives 40% Ticket Sales Increase in 2025

    AI Event Marketing Drives 40% Ticket Sales Increase in 2025

    PR Quantum
    November 4, 2025
  • CHETU EARNS GOLD GLOBEE® BUSINESS AWARD FOR ACHIEVEMENT IN TECHNOLOGY

    CHETU EARNS GOLD GLOBEE® BUSINESS AWARD FOR ACHIEVEMENT IN TECHNOLOGY

    PR Quantum
    November 4, 2025
  • Bonjour Girls Unveils 2025 ‘Roses & Planets’ — New York’s Premier Women’s Leadership Event Returns

    EIN Newswire
    November 4, 2025
  • Thornburg Income Builder Opportunities Trust Announces Distribution

    Thornburg Income Builder Opportunities Trust Announces Distribution

    Thornburg Investment Management Inc.
    November 4, 2025
  • Top Collision Center Serving Miami Shores for Over 30 Years

    Top Collision Center Serving Miami Shores for Over 30 Years

    PR Quantum
    November 4, 2025
  • NutraSabi Wasabi Supplements Now More Accessible

    NutraSabi Wasabi Supplements Now More Accessible

    PR Quantum
    November 4, 2025
  • U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

    U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

    UCB, INC.
    November 4, 2025
Prev
1 … 19,139 19,140 19,141 19,142 19,143 … 26,179
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.